Table 1 Comparison of clinical and pathological patient’s characteristics between low (<8.3%) and high (≥8.3%) ACI
From: Aortic calcification burden predicts deterioration of renal function after radical nephrectomy
non-CKD | pre-CKD | |||||
|---|---|---|---|---|---|---|
low ACI | high ACI | P value | low ACI | high ACI | P value | |
n | 40 | 36 | 13 | 20 | ||
Age, years | 57 (44–63) | 67 (62–75) | <0.001 | 62 (53–71) | 76 (74–79) | <0.001 |
Sex (Male) | 26 (65%) | 26 (72%) | 0.499 | 9 (69%) | 13 (65%) | 1.000 |
Comorbidities | ||||||
Hypertension | 9 (23%) | 11 (31%) | 0.426 | 1 (8%) | 9 (45%) | 0.050 |
Diabetes | 3 (8%) | 7 (19%) | 0.177 | 1 (8%) | 3 (15%) | 1.000 |
Cardiovascular disease | 2 (5%) | 2 (6%) | 1.000 | 0 (0%) | 1 (5%) | 1.000 |
Preoperative eGFR | 77 (68–87) | 74 (67–84) | 0.202 | 50 (42–54) | 42 (33–55) | 0.152 |
ACI (%) | 0.8 (0.0–5.8) | 18 (14–27) | <0.001 | 0.8 (0.0–3.3) | 18 (16–44) | <0.001 |
Tumor stage | ||||||
T1/2/3/4 | 25/6/7/2 | 23/3/10/0 | 0.394 | 7/4/2/0 | 13/3/3/1 | 0.810 |
Pathological subtype | 0.277 | 1.000 | ||||
Clear cell | 35 (88%) | 35 (97%) | 12 (92%) | 18 (90%) | ||
Papillary | 1 (2.5%) | 1 (3%) | 1 (8%) | 1 (5%) | ||
Chromophobe | 1 (2.5%) | 0 (0%) | 0 (0%) | 1 (5%) | ||
Others | 3 (7.5%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Distant metastasis | 6 (15%) | 3 (8%) | 0.494 | 2 (15%) | 3 (15%) | 1.000 |
Tumor recurrence | 9 (23%) | 5 (14%) | 0.334 | 2 (15%) | 2 (10%) | 1.000 |